Advertisement
Advertisement

Topic

solidarity

Health

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms. The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized patients. The International Steering Committee formulated the recommendation in light of the evidence for hydroxychloroquine vs standard-of-care and for lopinavir/ritonavir vs standard-of-care from the Solidarity trial interim results, and from a review of the evidence from all trials presented at the 1-2 July WHO Summit o

Health

Health – A Political Choice: Solidarity, Science and Solutions

Ending the COVID-19 pandemic is among the world’s most pressing priorities. The challenges we have all faced since the beginning of the outbreak have put health centre stage, highlighting the urgent need to invest resources and effort in strengthening health systems, addressing health inequities, and embracing innovation to find solutions to old and new problems. We will only find a way out of this crisis through science, finding solutions and by working together, in solidarity. In this new book, key leading figures in international health and development have come together to share their thou

Advertisement